Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients

BACKGROUND: Immunoglobulin (Ig) replacement therapy represents a life-saving treatment in primary antibody deficiencies. The introduction of subcutaneous Ig (SCIg) administration brings a major improvement in quality of life for patients, compared to the traditional intravenous administration. In re...

Descripción completa

Detalles Bibliográficos
Autores principales: Danieli, Maria Giovanna, Verga, Jacopo Umberto, Mezzanotte, Cristina, Terrenato, Irene, Svegliati, Silvia, Bilo, Maria Beatrice, Moroncini, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801806/
https://www.ncbi.nlm.nih.gov/pubmed/35111165
http://dx.doi.org/10.3389/fimmu.2021.805705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801806/
https://www.ncbi.nlm.nih.gov/pubmed/35111165
http://dx.doi.org/10.3389/fimmu.2021.805705

Ejemplares similares